Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Acetyl Penicillamine SCHEMBL34351 | 1.00 | MAPT (0.43) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetyl Penicillamine SCHEMBL521764 | 1.00 | MAPT (0.43) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetyl Penicillamine SCHEMBL15106832 | 0.92 | ALDH1A1 (0.41) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetyl Penicillamine SCHEMBL8398514 | 0.85 | ALDH1A1 (0.39) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL1236539 | 0.81 | CA2 (0.42) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL8415890 | 0.81 | CA2 (0.42) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL2515799 | 0.81 | CA2 (0.42) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL929561 | 0.80 | MAPT (0.58) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL3680194 | 0.80 | MAPT (0.37) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL21816921 | 0.80 | ALDH1A1 (0.41) | MAPTKDM4EALDH1A1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250109377-A1 | CELL CULTURE METHODS | UNIV MASSACHUSETTS (US) | 2025-04-03 | — | — | US | claimed |
| US-20250079000-A1 | METHODS AND MARKERS FOR DIAGNOSIS OF PARKINSON'S DISEASE | BERG SURVIVOR’S TRUST | 2025-03-06 | — | — | US | claimed |
| EP-4479519-A2 | CELL CULTURE METHODS | The University of Massachusetts (US) | 2024-12-25 | — | — | EP | claimed |
| CN-119013413-A | Cell culture method | 马萨诸塞大学 | 2024-11-22 | — | — | CN | claimed |
| US-12104106-B2 | Compositions of chiral molecules and perovskite nanocrystals and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2024-10-01 | — | — | US | claimed |
| WO-2024151479-A1 | CONTAINERS AND METHODS FOR NITRIC OXIDE STERILIZATION | STERILE STATE, LLC (US) | 2024-07-18 | — | — | WO | claimed |
| CN-117715664-A | Creation of cell-adhesive 3D printed objects using functionalized and non-functionalized ECM, ECM fragments, peptides and bioactive components | 朗格生物技术公共公益股份有限公司 | 2024-03-15 | — | — | CN | claimed |
| EP-4333917-A1 | USE OF FUNCTIONALIZED AND NON-FUNCTIONALIZED ECMS, ECM FRAGMENTS, PEPTIDES AND BIOACTIVE COMPONENTS TO CREATE CELL ADHESIVE 3D PRINTED OBJECTS | Lung Biotechnology PBC (US) | 2024-03-13 | — | — | EP | claimed |
| CN-117401836-A | Method for efficiently reducing polycyclic aromatic hydrocarbon pollutants by using biological Fenton and activated sludge coupling system and application of method | 中国石油化工股份有限公司 | 2024-01-16 | — | — | CN | claimed |
| WO-2023154910-A9 | CELL CULTURE METHODS | THE UNIVERSITY OF MASSACHUSETTS (US) | 2023-12-07 | — | — | WO | claimed |
| US-9371226-B2 | Methods for forming particles | BATTELLE ENERGY ALLIANCE, LLC (US) | 2016-06-21 | — | — | US | claimed |
| US-9212349-B2 | Method to produce virus in cultured cells | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2015-12-15 | — | — | US | claimed |
| EP-2606351-B1 | IN-SITU REAGENT FOR DETECTION OF PROTEINS | QUEEN MARY & WESTFIELD COLLEGE (GB) | 2015-05-06 | — | — | EP | claimed |
| US-20140113353-A1 | Method to Produce Virus in Cultured Cells | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2014-04-24 | — | — | US | claimed |
| EP-2699672-A1 | METHOD TO PRODUCE VIRUS IN CULTURED CELLS | The Trustees of Princeton University (US) | 2014-02-26 | — | — | EP | claimed |
| WO-2013158706-A1 | METHOD TO PRODUCE VIRUS IN CULTURED CELLS SUPPLEMENTED WITH ALPHA-KETOGLUTARATE | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2013-10-24 | — | — | WO | claimed |
| WO-2012145375-A1 | METHOD TO PRODUCE VIRUS IN CULTURED CELLS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2012-10-26 | — | — | WO | claimed |
| WO-2009151744-A1 | S-NITROSOMERCAPTO COMPOUNDS AND RELATED DERIVATIVES | GALLEON PHARMACEUTICALS, INC. (US) | 2009-12-17 | — | — | WO | claimed |
| US-20070243132-A1 | Transdermal delivery of pharmaceutical agents | APOLLO LIFE SCIENCES LIMITED (AU) | 2007-10-18 | — | — | US | claimed |
| EP-0165274-B1 | UTILIZATION OF CYSTEIN DERIVATIVES OR THE SALTS THEREOF TO ENHANCE INSULIN SECRETION OF THE ISLETS OF LANGERHANS OF THE PANCREAS | AMMON, Hermann P.T. (DE) | 1989-03-01 | — | — | EP | claimed |